Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate

European Journal of Contraception and Reproductive Health Care

Volumn 18, Issue 4, 2013, Pages 274-283

  Jensen, Jeffrey T ^a   Parke, Susanne ^b   Mellinger, Uwe ^b   Serrani, Marco ^b   Mabey, R Garn ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b BAYER PHARMA AG   (Germany)

^c Mountain View Hospital   (United States)

Author keywords

Dienogest; Headache; Hormone withdrawal associated symptoms; Oestradiol valerate; Oral contraception

Indexed keywords

DIENOGEST PLUS ESTRADIOL VALERATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORGESTIMATE; IBUPROFEN; PLACEBO; TRI CYCLEN; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; AMENORRHEA; ARTICLE; BREAST DISEASE; BREAST TENDERNESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSMENORRHEA; FEMALE; GASTROINTESTINAL DISEASE; GYNECOLOGIC DISEASE; HEADACHE; HORMONE WITHDRAWAL ASSOCIATED SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METRORRHAGIA; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PELVIS PAIN SYNDROME; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION; UTERINE CERVIX DYSPLASIA; VISUAL ANALOG SCALE; VOMITING;

ADULT; CONTRACEPTIVES, ORAL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; HEADACHE; HUMANS; MENSTRUATION; NANDROLONE; NORGESTREL; PELVIC PAIN; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880290153     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2013.785516     Document Type: Article

References (30)

1. P J, Scow R D , Preece C , et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000;95:261-6. (Pubitemid 30045651)
2. MacGregor EA , Frith A, Ellis J, et al. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006;67:2154-8. (Pubitemid 46035468)
3. MacGregor EA , Frith A , Ellis J, et al. Prevention of menstrual attacks of migraine: A double-blind placebocontrolled crossover study. Neurology 2006;67:2159-63. (Pubitemid 46035469)
4. MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004;3:354-61. (Pubitemid 38648856)
5. Nappi RE , Nappi G. Neuroendocrine aspects of migraine in women. Gynecol Endocrinol 2012;28(Suppl. 1):37-41.
6. Headache Classifi cation Subcommittee of the International Headache Society. The international classifi cation of headache disorders, 2nd edn. Cephalalgia 2004;24 (Suppl. 1): 9-160.
7. Allais G , Castagnoli Gabellari I , De Lorenzo C , et al. Oral contraceptives in migraine therapy. Neurol Sci 2011;32 (Suppl. 1): S135-9.
8. Allais G , Gabellari I C , A irola G , et al. Headache induced by the use of combined oral contraceptives. Neurol Sci 2009;30 (Suppl. 1): S15-7.
9. Spona J , Elstein M , Feichtinger W , et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996;54:71-7. (Pubitemid 26256707)
10. Sulak P, Willis S, Kuehl T, et al. Headaches and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache 2007;47:27-37. (Pubitemid 46096054)
11. Sulak P J, Cressman B E , Waldrop E , et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997;89:179-83. (Pubitemid 27057203)
12. Zeun S, Lu M, Uddin A , et al. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2009;14:221-32.
13. Merki-Feld G , Macias G , Parke S , et al. H ormone withdrawal-associated symptoms (headache and pelvic pain) in women taking combined oral contraceptives: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/levonorgestrel. Eur J Contracept Reprod Health Care 2012;17 (Suppl. 1): S100.
14. Loder EW , Buse DC , Golub JR. Headache as a side effect of combination estrogen-progestin oral contraceptives: A systematic review. Am J Obstet Gynecol 2005;193:636-49. (Pubitemid 41261456)
15. MacGregor E A , Chia H , Vohrah R C, et al. Migraine and menstruation: A pilot study. Cephalalgia 1990;10:305-10.
16. Johannes CB , Linet MS, Stewart WF, e t al. Relationship of headache to phase of the menstrual cycle among young women: A daily diary study. Neurology 1995;45:1076-82.
17. MacGregor A. Migraine associated with menstruation. Funct Neurol 2000;15(Suppl. 3):143-53. (Pubitemid 32051387)
18. Martelletti P , Farinelli I , Coloprisco G , et al. Role of NSAIDs in acute treatment of headache. Drug Dev Res 2007;68:276-81.
19. Lefebvre G, Pinsonneault O , Antao V, et al. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can 2005;27:1117-46.
20. Klipping C, Duijkers I , Trummer D , et al. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 2008;78:16-25.
21. Ruan X , Seeger H , Mueck A O. The pharmacology of dienogest. Maturitas 2012;71:337-44.
22. Ortho Tri-Cyclen â Lo Full Prescribing Information. Accessed 7 February 2013 from:http://www.myortho 360.com/sites/default/fi les/assets/Tri-Cyclen-Lo-PI. pdf#zoom-100
23. Kuhl H. Pharmacology of estrogens and gestagens. In: Fischl FH , ed. Menopause-Andropause: Hormone replacement therapy through the ages: New cognition and therapy concepts. Gablitz, Germany: Krause & Pachernegg GmbH 2001 :33-50.
24. Jensen M P, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC & Melzack R , eds. Handbook of pain assessment. New York: Guilford Press 2001 :15-34.
25. Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: A reanalysis of two clinical trials of postoperative pain. J Pain 2003;4:407-14. (Pubitemid 37122581)
26. Rowbotham MC. What is a "c linically meaningful" reduction in pain? Pain 2001;94:131-2. (Pubitemid 33016605)
27. Todd K H, Funk K G, Funk J P, et al. Clinical signifi cance of reported changes in pain severity. Ann Emerg Med 1996;27:485-9. (Pubitemid 26103814)
28. Moos R. Menstrual Distress Questionnaire (MDQ)-The standard method for measuring cyclical perimenstrual symptoms , 4th edn. Accessed 5 July 2012 from: http://www. mindgarden.com/products/mdq.htm
29. Busner J , Targum S D. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry 2007;4:28-37.
30. de Boer AG, van Lanschot JJ, Stalmeier PF, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004;13:311-20. (Pubitemid 38392259)